These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10081332)

  • 1. [A proposed open formulary for a managed care program in Mexico. The Therapeutic and Pharmacological Committee of Mexico].
    Salud Publica Mex; 1999; 41(1):27-41. PubMed ID: 10081332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The case for a value-based formulary: striving for total lowest net cost.
    Weart W; Bauman GR
    Manag Care Interface; 2007 Apr; 20(4):42-7. PubMed ID: 17474330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacy formularies in integrated health systems.
    Osborne JA
    J Healthc Resour Manag; 1997; 15(1):18-20. PubMed ID: 10164678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of pharmacoeconomics to formulary decision making in managed care organizations.
    Suh DC; Okpara IR; Agnese WB; Toscani M
    Am J Manag Care; 2002 Feb; 8(2):161-9. PubMed ID: 11858228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weighing the evidence: trends in managed care formulary decision making.
    de Lissovoy G
    J Clin Psychiatry; 2003; 64 Suppl 17():29-32. PubMed ID: 14680425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formularies in integrated health systems: Sharp HealthCare.
    Rizos AL; Levy E; Furnier J; Crowley K
    J Healthc Resour Manag; 1996 Sep; 14(7):14-9. PubMed ID: 10161585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulary decision-making considerations: COX-2 inhibitors.
    Shaya FT; Wong W; Shin JY; Martin L; Samant N
    Manag Care Interface; 2004 Nov; 17(11):29-36, 41. PubMed ID: 15573802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of health-related quality of life information in managed care formulary decision-making.
    Wu WK; Sause RB; Zacker C
    Res Social Adm Pharm; 2005 Dec; 1(4):579-98. PubMed ID: 17138497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do drug formulary policies reflect evidence of value?
    Neumann PJ; Lin PJ; Greenberg D; Berger M; Teutsch S; Mansley E; Weinstein MC; Rosen AB
    Am J Manag Care; 2006 Jan; 12(1):30-6. PubMed ID: 16402886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporating quality of life data into managed care formulary decisions: a case study with salmeterol.
    Bukstein DA
    Am J Manag Care; 1997 Nov; 3(11):1701-6. PubMed ID: 10178468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatologic formularies in the managed care setting.
    James WD
    Arch Dermatol; 1996 Sep; 132(9):1120-1. PubMed ID: 8795559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting formulary pull-through strategies: the role of pharmaceutical manufacturers.
    Navarro RP
    Manag Care Interface; 1999 May; 12(5):84-6. PubMed ID: 10537482
    [No Abstract]   [Full Text] [Related]  

  • 15. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporating clinical outcomes and economic consequences into drug formulary decisions: a practical approach.
    Mather DB; Sullivan SD; Augenstein D; Fullerton DS; Atherly D
    Am J Manag Care; 1999 Mar; 5(3):277-85. PubMed ID: 10351024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulary: what it is and how it works.
    Smith G
    J Healthc Resour Manag; 1996 Sep; 14(7):11-3. PubMed ID: 10161584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managed care and physicians' perceptions of drug formulary use.
    Fang H; Rizzo JA
    Am J Manag Care; 2009 Jun; 15(6):395-400. PubMed ID: 19514805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injectable drugs: the new frontier in pharmacy management.
    Rodgers JR
    Am J Manag Care; 2003 Jun; Suppl Decision Maker News():5-8. PubMed ID: 12866365
    [No Abstract]   [Full Text] [Related]  

  • 20. Managed care organizations: an introduction--Part I of II.
    Vogenberg FR
    Hosp Pharm; 1995 Jan; 30(1):40, 43-4. PubMed ID: 10139730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.